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SCIENTIFIC OPINION 
Scientific Opinion on Dietary Reference Values for biotin
1
 
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
2,3
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT  
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies 
(NDA) derived Dietary Reference Values (DRVs) for biotin. Biotin is a water-soluble vitamin which serves as a 
co-factor for several carboxylases that play critical roles in the synthesis of fatty acids, the catabolism of 
branched-chain amino acids and gluconeogenesis. Dietary biotin deficiency is rare. Data on biomarkers of biotin 
intake or status are insufficient to be used in determining the requirement for biotin. Data available on biotin 
intakes and health consequences are very limited and cannot be used for deriving DRVs for biotin. As there is 
insufficient evidence available to derive an Average Requirement and a Population Reference Intake, an 
Adequate Intake (AI) is proposed. The setting of AIs is based on observed biotin intakes with a mixed diet and 
the apparent absence of signs of deficiency in the EU, suggesting that current intake levels are adequate. The AI 
for adults is set at 40 µg/day. The AI for adults also applies to pregnant women. For lactating women, an 
additional 5 µg biotin/day over and above the AI for adults is proposed, to compensate for biotin losses through 
breast milk. For infants over six months, an AI of 6 µg/day is proposed by extrapolating from the biotin intake of 
exclusively breastfed infants aged zero to six months, using allometric scaling and reference body weight for 
each age group, in order to account for the role of biotin in energy metabolism. The AIs for children aged 1–3 
and 4–10 years are set at 20 and 25 µg/day, respectively, and for adolescents at 35 µg/day, based on observed 
intakes in the EU.  
© European Food Safety Authority, 2014 
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SUMMARY 
Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition 
and Allergies (NDA) was asked to deliver a scientific opinion on Dietary Reference Values (DRVs) 
for the European population, including biotin.  
In 1993, the Scientific Committee for Food proposed an Acceptable Range of Intakes of biotin for 
adults of 15–100 µg/day, based on observed intakes of biotin in European countries, which were 
considered adequate to meet requirements and prevent deficiency. 
Biotin is a water-soluble vitamin which serves as a co-factor for several carboxylases that play critical 
roles in the synthesis of fatty acids, the catabolism of branched-chain amino acids and 
gluconeogenesis. Dietary biotin deficiency is rare.  
Free biotin is absorbed nearly completely, while there is a lack of data on the absorption of protein-
bound biotin from foods. In the cell, biotin is covalently attached to biotin-dependent carboxylases, 
from which it can be released by other enzymes, or, alternatively, is catabolised through different 
pathways. Biotin and its metabolites are excreted in the urine.  
The Panel notes that biomarkers sensitive to biotin depletion have been identified. These include 
urinary biotin excretion and biomarkers of biotin function, such as urinary excretion of 3-
hydroxyisovaleric acid (3HIA) and 3HIA-carnitine, activity of propionyl-CoA carboxylase and 
abundance of biotinylated β-methylcrotonyl-CoA carboxylase and propionyl-CoA carboxylase in 
lymphocytes. However, data from the general population are limited so that the variability 
characteristics of these biomarkers and their ability to discriminate between biotin insufficiency and 
adequacy are not well known. Dose-response relationships between biotin intakes and these 
biomarkers have not been established. The Panel considers that data are insufficient to derive an 
Average Requirement (AR) for biotin from the use of available biomarkers of intake or status for any 
population group.  
Data available on biotin intakes and health consequences are very limited and cannot be used to 
derive DRVs for biotin.  
As the evidence to derive an AR, and thus a Population Reference Intake is considered insufficient, an 
Adequate Intake (AI) is proposed for all population groups. There is no indication that the AI should 
differ according to sex. The setting of AIs is based on observed biotin intakes with a mixed diet and 
the apparent absence of signs of deficiency in the EU, suggesting that current intake levels are 
adequate. Estimates of the biotin content of foods vary widely partly as a result of natural variation 
and partly depending on the analytical method used, and this contributes to uncertainty regarding 
current intake estimates. Estimates of biotin intakes in children, adolescents, adults and older adults 
were available from five EU countries. In boys and girls (5–12 years), mean/median intakes ranged 
from 19 to 38 µg/day, while mean/median intakes between 17 and 64 µg/day were reported for 
adolescent boys and girls (13–19 years). In adult men and women below about 65 years, mean/median 
intakes ranged from 26 to 50 µg/day, while mean/median intakes between 24 and 43 µg/day were 
reported for older adult men and women. 
The AI for adults is set at 40 µg/day. The AI for adults also applies to pregnant women. For lactating 
women, an additional 5 µg/day over and above the AI for adults is proposed, to compensate for biotin 
losses through breast milk. For infants over six months, an AI of 6 µg/day is proposed by 
extrapolating from the biotin intake of exclusively breastfed infants aged zero to six months, using 
allometric scaling (body weight to the power of 0.75) and reference body weight for each age group, 
in order to account for the role of biotin in energy metabolism, and rounding to the nearest unit. The 
AIs for children aged 1–3 and 4–10 years are set at 20 and 25 µg/day, respectively, and for 
adolescents at 35 µg/day, based on observed intakes in the EU. 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
The scientific advice on nutrient intakes is important as the basis of Community action in the field of 
nutrition, for example such advice has in the past been used as the basis of nutrition labelling. The 
Scientific Committee for Food (SCF) report on nutrient and energy intakes for the European 
Community dates from 1993. There is a need to review and if necessary to update these earlier 
recommendations to ensure that the Community action in the area of nutrition is underpinned by the 
latest scientific advice.  
In 1993, the SCF adopted an opinion on the nutrient and energy intakes for the European 
Community
4
. The report provided Reference Intakes for energy, certain macronutrients and 
micronutrients, but it did not include certain substances of physiological importance, for example 
dietary fibre. 
Since then new scientific data have become available for some of the nutrients, and scientific advisory 
bodies in many European Union Member States and in the United States have reported on 
recommended dietary intakes. For a number of nutrients these newly established (national) 
recommendations differ from the reference intakes in the SCF (1993) report. Although there is 
considerable consensus between these newly derived (national) recommendations, differing opinions 
remain on some of the recommendations. Therefore, there is a need to review the existing EU 
Reference Intakes in the light of new scientific evidence, and taking into account the more recently 
reported national recommendations. There is also a need to include dietary components that were not 
covered in the SCF opinion of 1993, such as dietary fibre, and to consider whether it might be 
appropriate to establish reference intakes for other (essential) substances with a physiological effect. 
In this context the EFSA is requested to consider the existing Population Reference Intakes for 
energy, micro- and macronutrients and certain other dietary components, to review and complete the 
SCF recommendations, in the light of new evidence, and in addition advise on a Population Reference 
Intake for dietary fibre.  
For communication of nutrition and healthy eating messages to the public it is generally more 
appropriate to express recommendations for the intake of individual nutrients or substances in food-
based terms. In this context the EFSA is asked to provide assistance on the translation of nutrient 
based recommendations for a healthy diet into food based recommendations intended for the 
population as a whole.  
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
In accordance with Article 29 (1)(a) and Article 31 of Regulation (EC) No 178/2002
5
, the 
Commission requests EFSA to review the existing advice of the Scientific Committee for Food on 
population reference intakes for energy, nutrients and other substances with a nutritional or 
physiological effect in the context of a balanced diet which, when part of an overall healthy lifestyle, 
contribute to good health through optimal nutrition.  
In the first instance the EFSA is asked to provide advice on energy, macronutrients and dietary fibre. 
Specifically advice is requested on the following dietary components:  
 Carbohydrates, including sugars; 
                                                     
4  Scientific Committee for Food, Nutrient and energy intakes for the European Community, Reports of the Scientific 
Committee for Food 31st series, Office for Official Publication of the European Communities, Luxembourg, 1993. 
5  Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general 
principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in 
matters of food safety. OJ L 31, 1.2.2002, p. 1-24. 
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 Fats, including saturated fatty acids, polyunsaturated fatty acids and monounsaturated fatty 
acids, trans fatty acids; 
 Protein; 
 Dietary fibre. 
Following on from the first part of the task, the EFSA is asked to advise on population reference 
intakes of micronutrients in the diet and, if considered appropriate, other essential substances with a 
nutritional or physiological effect in the context of a balanced diet which, when part of an overall 
healthy lifestyle, contribute to good health through optimal nutrition. 
Finally, the EFSA is asked to provide guidance on the translation of nutrient based dietary advice into 
guidance, intended for the European population as a whole, on the contribution of different foods or 
categories of foods to an overall diet that would help to maintain good health through optimal 
nutrition (food-based dietary guidelines). 
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ASSESSMENT 
1. Introduction 
In 1993, the Scientific Committee for Food (SCF) adopted an opinion on the nutrient and energy 
intakes for the European Community but was unable to define a specific physiological requirement of 
biotin for human health (SCF, 1993). The SCF noted that average intakes in adults in the European 
Community were about 28–42 µg/day, but that individuals consumed 15–100 µg/day. The SCF 
proposed an Acceptable Range of Intakes of biotin for adults of 15–100 µg/day, which was 
considered adequate to meet requirements and prevent deficiency. The SCF considered that there was 
no information on which to base additional requirements for biotin in pregnancy or lactation. The 
SCF did not set reference values for infants and children. 
2. Definition/category 
2.1. Chemistry 
Biotin is a bicyclic water-soluble vitamin that comprises an ureido ring fused with a 
tetrahydrothiophene ring, functionalised with a valeric acid side chain (Mock, 2014). It has a 
molecular mass of 244.31 Da. The only form found in nature that is biologically active is the isomer 
D(+)-biotin (Mock, 2014). 
Biotin in food and human tissues may occur in the free form or bound to protein. Microbiological 
assays and avidin-binding assays have most frequently been used to quantify biotin in foods and 
biological fluids. Assays need to account for interferences of biotin analogues and metabolites, as 
well as the need for prior acid or enzymatic hydrolysis necessary to measure protein-bound biotin 
(Mock and Malik, 1992; Lahely et al., 1999), which affect their specificity and sensitivity. Thus, both 
natural variation and analytical aspects may account for the variability of reported biotin 
concentrations in foods or body fluids and it is important to establish how biotin was quantified when 
comparing studies (SCF, 2001).  
High-performance liquid chromatography (HPLC)/avidin-binding assay is considered the most 
accurate and sensitive assay for quantification of biotin (IOM, 1998; SCF, 2001; Staggs et al., 2004). 
2.2. Function, physiology and metabolism 
Biotin is a co-factor for the enzymes acetyl-CoA carboxylase (ACC), propionyl-CoA carboxylase 
(PCC), β-methylcrotonyl-CoA carboxylase (MCC) and pyruvate carboxylase (PC), which play critical 
roles in the synthesis of fatty acids, the catabolism of branched-chain amino acids and 
gluconeogenesis (Zempleni and Mock, 1999c). Humans cannot synthesise biotin and depend on its 
dietary intake.  
At usual intakes, free biotin is absorbed nearly completely through a saturable carrier-mediated 
process. Absorption efficiency of free biotin is also high upon ingestion of large doses (up to 
20 mg/day) as a result of passive diffusion (Zempleni and Mock, 1999b). Protein-bound biotin 
requires to be released by biotinidase before absorption. The proportion of free biotin versus protein-
bound biotin varies among foods; the majority of biotin in meats and cereals is bound to protein 
(Zempleni and Mock, 1999c). There is a lack of data on the level of absorption of protein-bound 
biotin from foods. Avidin, a protein found in raw egg white, has a very high affinity for biotin and 
prevents its absorption in the small intestine. Faecal excretion of biotin has been observed to be three 
to six times higher than intakes, owing to the production of large amounts of biotin by the intestinal 
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microbiota; however, the extent to which biotin is absorbed from the large intestine and contributes to 
biotin requirements is uncertain (SCF, 2001).  
Once in plasma, biotin is transported as free biotin (81 %), as well as covalently or reversibly bound 
to plasma proteins (12 % and 7 %, respectively) (Mock, 2014). Biotin uptake into the liver and 
peripheral tissues occurs via a specific sodium-dependent, carrier-mediated process and by diffusion. 
In the cell, biotin is covalently attached to biotin-dependent carboxylases. Holocarboxylases can be 
degraded to biocytin or biotin-containing oligopeptides from which biotin can be released by 
biotinidase and re-used in the metabolism. The biotin that is not incorporated into carboxylase 
enzymes is catabolised through different pathways to form bisnorbiotin, tetranorbiotin and related 
intermediates, by β-oxidation of the valeric side-chain, or biotin sulphoxides and sulphone, by 
oxidation of the sulphur present in its heterocyclic ring (Mock, 2014). Biotin and its metabolites are 
excreted in the urine (Mock NI et al., 1997; Zempleni et al., 1997b). Biliary excretion of biotin and its 
metabolites is thought to be quantitatively negligible (Zempleni and Mock, 1999a), as indicated by 
data in rats and pigs (Zempleni et al., 1997a). Biotin metabolites do not have vitamin activity. 
Placental transport of biotin involves an active mechanism (Grassl, 1992; Wang et al., 1999; Mock, 
2014); from the second trimester, biotin concentrations have been observed to be 3- to 17-fold higher 
in the plasma of fetuses than in plasma of their mothers (Mantagos et al., 1998). 
The concentration of biotin in human milk has been observed to vary significantly among subjects, 
over the course of the day and as a function of time post partum (Mock et al., 1992; Mock DM et al., 
1997b). Mean concentrations of biotin in mature human milk measured by microbiological assays 
typically range between about 4 and 6 µg/L (data from Finland, the UK, Japan and the USA, up to one 
year of lactation) (Goldsmith et al., 1982; Ford et al., 1983; Salmenpera et al., 1985; Hirano et al., 
1992; Sakurai et al., 2005) (Appendix A). Using an HPLC/avidin-binding assay, Mock DM et al. 
(1997b) reported mean biotin concentrations in mature milk of around 7 µg/L in a cohort of 15 
healthy breastfeeding women in the USA who were not consuming daily supplements containing 
more than 4 g biotin (about 10 % of daily intake).  
Dietary biotin deficiency is rare and is characterised by fine scaly dermatitis, hair loss, conjunctivitis, 
ataxia and delayed child development (Zempleni and Mock, 1999c). Cases of biotin deficiency have 
been observed in patients receiving long-term total parenteral nutrition without biotin 
supplementation and in patients with biotinidase deficiency, as well as in people who had consumed 
large amounts of raw eggs (Zempleni and Mock, 1999c). Biotin deficiency during pregnancy has been 
shown to be teratogenic in several species, including mice, hamsters, chicken and turkeys (Said, 1999; 
Zempleni and Mock, 2000; Mock, 2005), but no data are available in humans indicative of an 
association between biotin deficiency in pregnancy and an increased incidence of fetal malformations.  
The SCF could not derive a Tolerable Upper Intake Level (UL) and stated that available evidence 
indicates that observed levels of intake of biotin from all sources do not represent a health risk for the 
general population (SCF, 2001). 
Although biotin and pantothenic acid have been shown to share common carrier-mediated uptake 
mechanisms in vitro (Said, 2009), the nutritional implications of this interaction are not known. 
2.3. Biomarkers 
Mock and his collaborators have studied urinary and blood biomarkers of biotin status by providing 
healthy men and women with a biotin-depleted diet based on raw egg white, to induce asymptomatic 
biotin insufficiency. Between 7 and 11 subjects were involved in each study and depletion lasted for 
three to four weeks. The 24-hour urinary excretion of biotin was found to decrease significantly over 
the depletion period (Mock NI et al., 1997; Mock et al., 2002a), while plasma concentration of biotin 
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was not significantly affected (Mock NI et al., 1997). Biotin insufficiency was also shown to affect 
markers of the activities of biotin-dependent carboxylase enzymes and related metabolic pathways. 
The 24-hour urinary excretion of 3-hydroxyisovaleric acid (3HIA) and 3HIA-carnitine, as well as 
fasting plasma 3HIA-carnitine concentration, were found to increase significantly in male and female 
subjects over the depletion period, indicating a reduced activity of MCC (Mock NI et al., 1997; Mock 
et al., 2002a; Horvath et al., 2010b; Horvath et al., 2010a; Stratton et al., 2011). Pooling of data from 
two sources (Mock NI et al., 1997; Mock et al., 2002a) indicated that urinary excretion of 3HIA or 
biotin did not differ between sexes, either before egg white feeding or at day 21 of depletion (Mock et 
al., 2002a). Urinary excretion of 3HIA and 3HIA-carnitine was also shown to significantly increase in 
response to an oral challenge of leucine, an amino acid whose degradation requires MCC (Mock et 
al., 2002a; Mock et al., 2011). A decrease in PCC activity in lymphocytes and, more recently, an 
increase in the ratios of acylcarnitines in urine, arising from acyl-CoA substrates and their products, 
which reflect disturbances in biotin-dependent carboxylase activities, were also observed in response 
to induced biotin insufficiency (Stratton et al., 2006; Bogusiewicz et al., 2012).  
In a randomised cross-over study in 16 healthy non-smoking men and women (21–45 years), possible 
markers of biotin status were assessed. Each subject followed three intervention phases of three weeks 
each interrupted by wash-out periods of two weeks, i.e. biotin “depletion” (using an egg white diet), 
“sufficiency” (habitual diet supplemented with 30 µg/day of biotin) and “supplementation” (habitual 
diet supplemented with 600 µg/day of biotin) (Eng et al., 2013). Significant differences in the 
amounts of biotinylated MCC and PCC in lymphocytes were observed between the three 
interventions. Urinary excretion of biotin did not differ between the “biotin-deficient” and “biotin-
sufficient” interventions. Average urinary excretion of 3HIA was twice as high during the “biotin-
deficient” intervention as during the two other interventions. However, for 8 of the 16 subjects, the 
urinary excretion of 3HIA did not increase during biotin “depletion” compared with the other 
intervention periods. The amount of mRNAs coding for biotin-dependent carboxylases, biotin 
transporters and holocarboxylase synthetase in lymphocytes was not different among the 
interventions.  
Smoking (Sealey et al., 2004) and the use of some anticonvulsant drugs (Mock and Dyken, 1997; 
Mock et al., 1998) were also found to increase urinary excretion of 3HIA and to increase ratios of 
urinary biotin catabolites to biotin, indicating increased catabolism of biotin. 
The Panel notes that biomarkers sensitive to biotin depletion have been identified in adults. These 
include urinary biotin excretion and biomarkers of biotin function, such as urinary excretion of 3HIA 
and 3HIA-carnitine, and PCC activity and abundance of biotinylated MCC and PCC in lymphocytes. 
However, data from the general population are limited so that the variability characteristics of these 
biomarkers and their ability to discriminate between biotin insufficiency and adequacy are not well 
known. Dose-response relationships between biotin intakes and these biomarkers have not been 
established.  
3. Dietary sources and intake data  
3.1. Dietary sources 
Staggs et al. (2004) compared the biotin content of 87 foods measured by HPLC/avidin-binding assay 
to values published from earlier analyses, mostly using bioassays. This study confirmed previous 
assessments that meat, fish, poultry, egg, some cheeses and some vegetables are rich dietary sources 
of biotin. The HPLC/avidin-binding assay showed that the richest sources of biotin are liver (416 ng/g 
wet weight), eggs (214 ng/g wet weight), mushrooms (22 ng/g wet weight) and some cheeses (15–
30 ng/g wet weight), while smaller amounts are found in lean meat, fruit, cereals and bread (1–10 ng/g 
wet weight). Most previously published values were higher than those measured by the HPLC/avidin-
binding assay. Differences may relate to the natural variation of the biotin content of foods 
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(depending on, for instance, growing conditions, season, geographic origin, processing), as well as to 
differences in the specificity and sensitivity of the HPLC/avidin-binding assay and bioassays inherent 
to these methodologies (see Section 2.1).  
Currently, D-biotin may be added to foods
6
 and food supplements.
7
 The biotin content of infant and 
follow-on formulae is regulated.
8
 
3.2. Dietary intakes  
Estimates of biotin intakes in children and adolescents, adults and older adults from five EU countries 
(Austria, Germany, Hungary, Ireland and Latvia, data collected between 2003 and 2010) are provided 
in Appendices B, C and D, respectively. Values were calculated from individual consumption data 
collected from dietary history, three-/four-day dietary records, or 24-hour recall, combined with 
analytical data from food composition tables. Dietary intake data are prone to reporting errors and 
there is a varying degree of under-reporting in different surveys (Merten et al., 2011). Although the 
differences in methodologies have an impact on the accuracy of between-country comparisons, the 
data presented give an overview of the biotin intake in a number of European countries. 
In young children aged 1–4 years, median intakes ranged from 19 to 28 µg/day. A median biotin 
intake of 19 µg/day was observed in Irish boys and girls (IUNA, online-a). Median biotin intakes of 
25 µg/day and 28 µg/day were observed in German girls and boys, respectively (DGE, 2012). 
In boys and girls aged 5–12 years, mean/median intakes ranged from 19 to 38 µg/day. Median intakes 
ranged from 19 to 24 µg/day in Ireland (boys and girls, 5–12 years), and were reported to be 
36 µg/day in girls and 38 µg/day in boys in Germany (6–11 years), while mean intakes ranged from 
30 to 35 µg/day in Austria (boys and girls, 7–12 years). 
In adolescent boys and girls aged 13–19 years, mean/median intakes ranged from 17 to 64 µg/day. 
Median intakes ranged from 17 to 27 µg/day in Ireland (boys and girls, 13–19 years) and were 
reported to be 36 µg/day in girls and 45 µg/day in boys (15–19 years, determined by 24-hour recall) or 
50 µg/day in girls and 64 µg/day in boys (12–17 years, using dietary history over four weeks) in 
Germany. Mean intakes ranged from 31 to 47 µg/day in Austria (boys and girls, 13–19 years).  
In adult men and women below about 65 years, mean/median intakes ranged from 26 to 50 µg/day. 
Data from Germany and Ireland indicated median intakes between 40 and 48 µg/day in men and 
between 29 and 42 µg/day in women, while mean intakes were observed to range between 33 and 
50 µg/day in men and 26 and 43 µg/day in women in Hungary and Austria, and between 34 and 
45 µg/day for both sexes in Latvia.  
In older adult men and women, mean/median intakes ranged from 24 to 43 µg/day. Median intakes 
between 36 and 43 µg/day in men and 32 and 39 µg/day in women were observed in Germany and 
Ireland and mean intakes of 29 to 34 µg/day in men and 24 to 34 µg/day in women were reported in 
Hungary and Austria. 
Data on biotin intakes in pregnancy are scarce. Using a 24-hour recall, mean intakes of 49 µg/day and 
48 µg/day were reported in 87 Viennese and 426 Austrian pregnant women, respectively (Elmadfa et 
al., 2004; Elmadfa et al., 2009). Some intake estimates are also available from an observational study 
conducted in the UK, in which mean intakes of biotin in a population of 123 pregnant women were 
                                                     
6  Regulation (EC) No 1925/2006 of the European Parliament and of the Council of 20 December 2006 on the addition of 
vitamins and minerals and of certain other substances to foods, OJ L 404, 30.12.2006, p. 26.  
7
  Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of 
the Member States relating to food supplements, OJ L 183, 12.7.2002, p. 51.  
8  Commission Directive 2006/141/EC of 22 December 2006 on infant formulae and follow-on formulae and amending 
Directive 1999/21/EC, OJ L 401, 30.12.2006, p. 1. 
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18 ± 7 µg/day (range 5–37 µg/day), using a food frequency questionnaire and 19 ± 10 µg/day (range 
5–79 µg/day), using 24-hour recall (Mouratidou et al., 2006).  
The Panel notes that estimates of the biotin content of foods vary widely partly as a result of natural 
variation and partly depending on the analytical method used (see Sections 2.1 and 3.1), and that this 
contributes to uncertainty regarding current intake estimates.  
4. Overview of Dietary Reference Values and recommendations 
Several national and international authorities have proposed reference values or recommendations for 
biotin intakes. There has been consensus so far that evidence is lacking to establish an Average 
Requirement (AR) for biotin. Rather, Adequate or Acceptable Ranges of Intakes have been proposed 
(Table 1). The Nordic countries did not set a reference value for biotin (NNR, 2012).  
4.1. Adults 
The SCF (1993), the UK Committee on Medical Aspects of Food Policy (COMA) (DH, 1991) and the 
German-speaking countries (D-A-CH, 2013) set Acceptable Ranges of Intakes, and the French Food 
Safety Agency (Afssa, 2001) set Adequate Intakes (AIs), based on data from dietary intake surveys, 
considering the absence of deficiency at observed intakes. The US Institute of Medicine (IOM, 1998) 
and the World Health Organization / Food and Agriculture Organization of the United Nations 
(WHO/FAO, 2004) proposed AIs derived from upward extrapolation of the AI for infants using 
allometric scaling (body weight to the power of 0.75 and reference body weights).  
4.2. Infants and children 
The German-speaking countries (D-A-CH, 2013), WHO/FAO (2004), Afssa (2001) and IOM (1998) 
proposed AIs for infants based on estimated biotin intakes with human milk in exclusively breastfed 
infants. WHO/FAO (2004) and IOM (1998) derived AIs for children and adolescents from upward 
extrapolation of the AI for infants using allometric scaling (body weight to the power of 0.75 and 
reference body weights), while Afssa (2001) scaled down from the AI for adults using height squared 
as the basis for extrapolation. 
4.3. Pregnancy and lactation 
Although an increase in urinary excretion of 3HIA and a decrease in urinary excretion of biotin have 
been observed in some pregnant women (Mock and Stadler, 1997; Mock DM et al., 1997a), data have 
been considered insufficient to derive a specific reference value for pregnant women (IOM, 1998; 
Afssa, 2001; WHO/FAO, 2004). The AI set for adults was considered to be sufficient to cover the 
period of pregnancy. 
An additional intake of 5 µg/day has generally been proposed for lactating women to cover biotin 
losses due to breastfeeding, considering the amount of biotin that would be excreted by women 
breastfeeding exclusively (IOM, 1998; Afssa, 2001; WHO/FAO, 2004). 
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Table 1:  Overview of Dietary Reference Values for biotin 
 D-A-CH 
(2013) 
WHO/FAO 
(2004) 
Afssa 
(2001) 
IOM 
(1998) 
SCF 
(1993) 
DH 
(1991) 
Infants       
Age (months) 4–<12 7–12 0–12 7–12   
AI (µg/day) 5–10 (a) 6 6 6 – – 
Children and adolescents     
Age (years) 1–<4 1–3 1–3 1–3   
AI (µg/day) 10–15 (a)  8 12 8 – – 
Age (years) 4–<7 4–6 4–6 4–8   
AI (µg/day) 10–15 (a)  12 20 12 – – 
Age (years) 7–<10 7–9 7–9 9–13   
AI (µg/day) 15–20 (a) 20 25 20 – – 
Age (years) 10–<13 10–18 10–12 14–18   
AI (µg/day) 20–30 (a) 25 35 25 – – 
Age (years) 13–<19  13–15    
AI (µg/day) 25–35 (a) – 45 – – – 
Age (years)   16–19    
AI (µg/day) – – 50 – – – 
Adults       
Age (years) ≥ 19 ≥ 19 > 19 ≥ 19  ≥ 19 ≥ 19 
AI (µg/day) 30–60 (a) 30 50 30 15–100 (a) 10–200 (a) 
Age (years)   ≥ 75    
AI (µg/day) – – 60  – – – 
Pregnancy       
AI (µg/day) 30–60 (a) 30 50 30 15–100 (a) – 
Lactation       
AI (µg/day) 30–60 (a) 35 55 35 15–100 (a) – 
(a): Acceptable Range of Intakes. 
5. Criteria (endpoints) on which to base Dietary Reference Values 
5.1. Indicators of biotin requirement 
The Panel considers that data are insufficient to derive the AR for biotin from the use of available 
biomarkers of intake or status for any population group.  
5.2. Biotin intake and health consequences 
Data examining the relationship between biotin intake and health outcomes are scarce. 
A comprehensive search of the literature published between January 1990 and July 2012 was 
performed as preparatory work to this assessment, to identify relevant health outcomes upon which 
DRVs for biotin may potentially be based (Eeuwijk et al., 2012). Three cross-sectional studies were 
retrieved, which investigated associations between biotin intakes and genome damage (Fenech et al., 
2005) or blood pressure (Schutte et al., 2003b, 2003a). 
The Panel considers that the data available from these studies are very limited and cannot be used to 
derive DRVs for biotin.  
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5.3. Specific considerations for pregnancy and lactation 
The Panel notes that urinary excretion of 3HIA has been observed to be higher in pregnant women 
than in non-pregnant women, while results on urinary biotin excretion were inconsistent (Mock and 
Stadler, 1997; Mock DM et al., 1997a; Shibata et al., 2013). However, biotin intake levels were not 
reported in these studies and the relevance of these findings with respect to biotin status in pregnancy 
is unclear. Another study (Mock et al., 2002b) was of insufficient duration (i.e. two weeks) to allow 
conclusions with respect to changes in biomarkers of biotin status (urinary 3HIA and biotin 
excretions) in unsupplemented pregnant women. 
No data on an association between biotin insufficiency in pregnancy and increased incidence of fetal 
malformations in humans are available (see Section 2.2).  
Assuming an average breast milk biotin concentration of 5 g/L (see Section 2.2) and an average 
breast milk secretion of 0.8 L/day over the first six months of lactation (Butte et al., 2002; 
FAO/WHO/UNU, 2004; EFSA NDA Panel, 2009), the Panel notes that mean biotin secretion in milk 
is 4 g/day in fully breastfeeding women.  
6. Data on which to base Dietary Reference Values 
The Panel considers that the available data are insufficient to derive ARs and PRIs for biotin, and 
therefore proposes to set an AI for all population groups. The setting of an AI for biotin is based on 
observed biotin intakes with a mixed diet and the apparent absence of signs of deficiency in the EU, 
suggesting that current intake levels are adequate. There is no indication that the AI should differ 
according to sex. 
6.1. Adults 
The Panel chooses the approximate midpoint of the observed mean/median intakes (Appendices C 
and D) to set an AI for biotin at 40 µg/day for adults of all ages.  
6.2. Infants, children and adolescents 
Assuming an average breast milk biotin concentration of 5 µg/L (see Section 2.2) and an average 
breast milk intake of infants aged 0–6 months of 0.8 L/day (Butte et al., 2002; FAO/WHO/UNU, 
2004; EFSA NDA Panel, 2009), the estimated biotin intake of infants between zero and six months is 
4 µg/day. The AI for infants over six months of age can be derived by extrapolation from this figure, 
using allometric scaling (body weight to the power of 0.75) and reference body weight of each age 
group
9
 (WHO Multicentre Growth Reference Study Group, 2006), in order to account for the role of 
biotin in energy metabolism, and rounding to the nearest unit. The AI for infants aged 7–11 months is 
set at 6 µg/day.  
The Panel sets an AI for biotin of 20 µg/day for young children (1–3 years), based on observed 
median intakes in this age group. In consideration of the AI set for infants in the second half year of 
life, a value at the lower end of the range of observed intakes was chosen. The Panel sets an AI of 
25 µg/day for children (4–10 years) and 35 µg/day for adolescents (11–17 years) (Table 2), based on 
the approximate midpoint of the observed mean/median intakes of each age group (Appendix B).  
                                                     
9  Mean of body weight-for-age at 50th percentile of male and female infants aged three and nine months.  
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6.3. Pregnancy and lactation 
The Panel considers that data are insufficient to derive a specific AI for biotin in pregnancy. The 
Panel considers that the AI for adults of 40 µg/day also applies to pregnant women.  
Considering average biotin losses through breast milk of 4 µg/day during lactation (see Section 5.3) 
and rounding up, the Panel proposes to increase the AI for lactating women to 45 µg/day.  
CONCLUSIONS 
The Panel concludes that there is insufficient evidence to derive an Average Requirement (AR) and a 
Population Reference Intake (PRI) for biotin. Suitable data on biotin intake or status and health 
outcomes were not available for the setting of DRVs for biotin. Thus, the Panel proposes an Adequate 
Intake (AI) for adults based on observed intakes in the EU. It was considered unnecessary to give sex-
specific values. The Panel proposes that the AI for adults also applies to pregnant women. For 
lactating women, an increment in the adult AI is proposed, in order to compensate for biotin losses 
through secretion of breast milk. An AI is also proposed for infants aged 7–11 months based on 
extrapolation from the estimated intake of infants aged zero to six months using allometric scaling, 
and for children and adolescents based on observed intakes in the EU. 
Table 2:  Summary of Adequate Intakes for biotin 
Age Adequate Intake ( g/day) 
7–11 months 6 
1–3 years 20 
4–10 years 25 
11–17 years 35 
≥ 18 years (a) 40 
Lactation 45 
(a): Including pregnancy.  
RECOMMENDATIONS FOR RESEARCH 
The Panel recommends to review analytical data for biotin in food composition tables, to reflect the 
most reliable quantification methods. Dietary biotin intakes should be reassessed accordingly, in order 
to ascertain current AIs for biotin. 
The Panel recommends further research on the dose-response relationships between biotin intake and 
functional biomarkers (e.g. markers of activities of biotin-dependent carboxylases) to characterise an 
adequate biotin status and to allow the derivation of the requirement for biotin.  
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APPENDICES 
Appendix A.  Biotin concentration of human milk from healthy mothers of term infants 
Reference Number of women 
(number of samples) 
Country Total maternal intake 
(µg/day), mean 
(range) 
Plasma concentration 
(ng/L) 
Stage of 
lactation 
Biotin concentration 
(µg/L) 
Method of analysis 
Mean ± SD Range 
Sakurai et al. 
(2005) 
    (6) 
    (6) 
  (34) 
  (34) 
  (34) 
  (60) 
  (69) 
(129) 
Japan Not reported 
(a)
 Not reported 6–10 days 
11–20 days 
21–89 days 
90–180 days 
181–365 days 
Summer 
Winter 
Overall 
2.8 ± 2.7 
5.9 ± 4.0 
5.8 ± 2.4 
4.8 ± 1.7 
4.2 ± 1.7 
4.7 ± 2.2 
5.2 ± 2.3 
5.0 ± 2.3 
n.a. Microbiological assay 
(Lactobacillus arabinosus) 
Mock DM et 
al. (1997b) 
  15 USA Dietary supplement 
containing < 4 µg 
(~10 % of daily intake) 
Not reported 8 days 
36 days 
~ 2.0 
~ 6.8  
n.a. HPLC/avidin-binding 
assay 
Hirano et al. 
(1992) 
38 (102) Japan Not reported 
(b)
 Not reported 0–5 days 
6–14 days 
15–24 days 
0.8 ± 0.6  
1.8 ± 1.4 
5.2 ± 2.1 
n.a. Microbiological assay 
(Lactobacillus plantarum, 
ATCC 8014) 
Salmenpera 
et al. (1985) 
200 
n.a. 
116 
  36 
Finland Not reported 
(c)
 250 
(d)
 
330 
(d)
 
330 
(d)
 
330 
(d) 
 
0 months 
2 months 
6 months 
9 months 
n.d.  
4.5 
(d)
 
4.5 
(d)
 
4.5 
(d)
 
n.a. 
n.d.–27  
n.d.–18  
1.8–10  
Microbiological assay 
(Lactobacillus plantarum, 
ATCC 8014) 
Ford et al. 
(1983) 
  35 UK Not reported 
(b)
 Not reported 
 
1–5 days 
6–15 days 
16–244 days 
0.21 
2.21 
5.30 
0.02–0.83 
0.05–8.0 
0.60–12.0 
„Standard microbiological 
methods‟ 
Goldsmith et 
al. (1982) 
 
  84 
  67 
  64 
USA Not reported 
(b)
 Not reported 3–8 days 
10–14 days 
30–47 days 
0.7 ± 0.9
 
3.0 ± 2.2 
4.7 ± 2.2 
0.0–7.2 
0.1–11.8 
0.5–14.1 
Microbiological assay 
(Lactobacillus plantarum 
ATCC 8014) 
(a): Not taking supplements. 
(b): No indication of supplementation. 
(c): No supplementation during lactation or pregnancy.  
(d): Geometric mean.  
n.a., not available; n.d., non-detectable. 
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Appendix B.  Biotin intake among children and adolescents in European countries 
Country Reference Dietary assessment method (year of survey) 
(a)
 Age 
(years) 
n Mean 
(µg/day) 
SD Median 
(µg/day) 
P5–P95 
Boys         
Austria Elmadfa et al. (2009) Seven-day record (2003) 7–9 n.a. 34 n.a. n.a. n.a. 
   10–12 n.a. 35 n.a. n.a. n.a. 
   13–15 n.a. 34 n.a. n.a. n.a. 
  Three-day record (2007–2008) 7–9 148 33 n.a. n.a. n.a. 
   10–12 155 32 n.a. n.a. n.a. 
   13–15 86 33 n.a. n.a. n.a. 
  24-hour recall (2004) (Berufsschüler/ 
allgemeinbildende höhere Schulen-Schüler) (from 
Vienna) 
14–19 35/47 35/47 n.a. n.a. n.a. 
Germany DGE (2008) Three-day record (2001–2002) 1–< 4 242 n.a. n.a. 30.9 n.a. 
 DGE (2008) Three-day record (2001–2002) 4–< 5 242 n.a. n.a. 28.2 n.a. 
 Mensink et al. (2007)  Three-day record (2006) 6–11 626 48.2 n.a. 38.2  22.2–119.4 
 Mensink et al. (2007)  Dietary history (over the last four weeks) (2006) 12–17 622 96.7 n.a. 63.5 27.9–265.6 
 DGE (2012) Two non-consecutive 24-hour recalls (2005–2006) 15–19 506 n.a. n.a. 45.0 n.a. 
Ireland IUNA (online-b) Seven-day record (2003–2004) 5–8 145 26.0 23.8 19.7 9.2–65.4
 
 
 IUNA (online-b) Seven-day record (2003–2004) 9–12 148 27.8 22.0 24.2 9.9–57.7 
 IUNA (online-c) Seven-day record (2005–2006) 13–14 95 34.4 34.1 25.0 11.0–119.5 
 IUNA (online-c) Seven-day record (2005–2006) 15–17 129 40.5 41.5 27.0 14.0–131.5 
Girls         
Austria Elmadfa et al. (2009) Seven-day record (2003) 7–9 n.a. 30 n.a. n.a. n.a. 
   10–12 n.a. 33 n.a. n.a. n.a. 
   13–15 n.a. 31 n.a. n.a. n.a. 
  Three-day record (2007–2008) 7–9 175 31 n.a. n.a. n.a. 
   10–12 152 29 n.a. n.a. n.a. 
   13–15 64 27 n.a. n.a. n.a. 
  24-hour recall (2004) (Berufsschüler/ 
allgemeinbildende höhere Schulen-Schüler) (from 
Vienna) 
14–19 28/39 28/39 n.a. n.a. n.a. 
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Country Reference Dietary assessment method (year of survey) 
(a)
 Age 
(years) 
n Mean 
(µg/day) 
SD Median 
(µg/day) 
P5–P95 
Germany DGE (2008) Three-day record (2001–2002) 1–< 4 246 n.a. n.a. 25.4 n.a. 
 DGE (2008) Three-day record (2001–2002) 4–< 5 246 n.a. n.a. 29.3 n.a. 
 Mensink et al. (2007)  Three-day record (2006) 6–11 608 44.7 n.a. 35.7 17.9–106.5 
 Mensink et al. (2007)  Dietary history (over the last four weeks) (2006) 12–17 650 84.4 n.a. 49.5 22.8–266.8 
 DGE (2012) Two non-consecutive 24-hour recalls (2005–2006) 15–19 536 n.a. n.a. 36.0 n.a. 
Ireland IUNA (online-b) Seven-day record (2003–2004) 5–8 151 23.3 26.5 19.1 9.9–52.2 
 IUNA (online-b) Seven-day record (2003–2004) 9–12 150 24.4 24.3 19.6 9.1–61.5 
 IUNA (online-c) Seven-day record (2005–2006) 13–14 93 27.5 50.1 16.5 7.7–79.1 
 IUNA (online-c) Seven-day record (2005–2006) 15–17 124 24.6 20.4 20.5 6.9–66.0 
Both sexes        
Ireland 
IUNA (online-a) Four-day weighed dietary record (2010–2011) 1–4 500 22.9 16.3 19.3 9.9–53.4 
(a): Supplements excluded. 
n.a., not available; P5, 5th percentile; P95, 95th percentile. 
Dietary Reference Values for biotin 
 
EFSA Journal 2014;12(2):3580 21 
Appendix C.  Biotin intake among adults aged ~ 19–65 years in European countries 
Country Reference Dietary assessment method (year of survey) 
(a)
 Age (years) n Mean 
(µg/day) 
SD Median P5–P95 
Men         
Austria Elmadfa et al. (2009) 24-hour recall 18–25 93 50 n.a. n.a. n.a. 
   25–51 541 44 n.a. n.a. n.a. 
   51–64 144 42 n.a. n.a. n.a. 
Germany
 DGE (2012) Two non-consecutive 24-hour recalls (2005–2006) 19–24 469 n.a. n.a. 46 n.a. 
  25–34 614 n.a. n.a. 48 n.a. 
  35–50 1 946 n.a. n.a. 48 n.a. 
  51–64 1 460 n.a. n.a. 47 n.a. 
Hungary Zajkas et al. (2007) Three-day record (2003–2004) 18–34 136 32.5 8.4 n.a. n.a. 
   35–59 199 32.6 9.3 n.a. n.a. 
Ireland IUNA (2011) Four-day record (2008–2010) 18–64 634 42 18 40 19-72 
Women         
Austria Elmadfa et al. (2009) 24-hour recall 18–25 187 41    
   25–51 959 42    
   51–64 199 43    
Germany
 DGE (2012) Two non-consecutive 24-hour recalls (2005–2006) 19–24 486 n.a. n.a. 39 n.a. 
  25–34 852 n.a. n.a. 42 n.a. 
  35–50 2 648 n.a. n.a. 41 n.a. 
  51–64 1 740 n.a. n.a. 41 n.a. 
Hungary Zajkas et al. (2007) Three-day record (2003–2004) 18–34 176 26.9 8.6 n.a. n.a. 
   35–59 295 26.2 8.0 n.a. n.a. 
Ireland IUNA (2011) Four-day record (2008–2010) 18–64 640 32 17 29 13-58 
Both sexes         
Latvia Joffe et al. (2009) Two non-consecutive 24-hour dietary recalls + food 
frequency questionnaire (2008) 
17–26 378 34.3 n.a. n.a. n.a. 
  27–36 206 36.3 n.a. n.a. n.a. 
  37–46 272 35.0 n.a. n.a. n.a. 
  47–56 304 34.8 n.a. n.a. n.a. 
  57–64 217 45.4 n.a. n.a. n.a. 
(a):  Supplements excluded. 
n.a., not available; P5, 5th percentile; P95, 95th percentile. 
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Appendix D.  Biotin intake among adults aged ~ 65 years and over in European countries 
Country Reference Dietary assessment method  
(year of survey) 
(a)
 
Age (years) n Mean 
(µg/day) 
SD Median 
(µg/day) 
P5–P95 
Men         
Austria Elmadfa et al. (2009) Three-day record (2007–2008) ≥ 55 121 34 n.a. n.a. n.a. 
Germany
 DGE (2012) Two non-consecutive 24-hour recalls (2005-2006) 65–80 1 165 n.a. n.a. 43 n.a. 
Hungary Zajkas et al. (2007) Three-day record (2003–2004) ≥ 60 138 29.1 8.5 n.a. n.a. 
Ireland IUNA (2011) Four-day record (2008–2010) ≥ 65 106 40 19 36 17–68 
Women         
Austria Elmadfa et al. (2009) Three-day record (2007–2008) ≥ 55 302 34 n.a. n.a. n.a. 
Germany
 DGE (2012) Two non-consecutive 24-hour recalls (2005–2006) 65–80 1 331 n.a. n.a. 39 n.a. 
Hungary Zajkas et al. (2007) Three-day record (2003–2004) ≥ 60 235 24.5 7.8 n.a. n.a. 
Ireland IUNA (2011) Four-day record (2008–2010) ≥ 65 120 37 28 32 18–61 
(a):  Supplements excluded. 
n.a., not available; P5, 5th percentile; P95, 95th percentile. 
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ABBREVIATIONS 
ACC acetyl-CoA carboxylase 
Afssa Agence française de sécurité sanitaire des aliments  
AI Adequate Intake 
AR Average Requirement 
CoA coenzyme A 
COMA Committee on Medical Aspects of Food Policy 
D-A-CH Deutschland- Austria- Confoederatio Helvetica 
DGE Deutsche Gesellschaft für Ernährung  
DRV Dietary Reference Value 
DH Department of Health 
DRV Dietary Reference Value 
EC European Commission 
EFSA European Food Safety Authority 
EU European Union 
FAO Food and Agriculture Organization 
3HIA 3-hydroxyisovaleric acid 
HPLC high-performance liquid chromatography 
IOM US Institute of Medicine of the National Academy of Sciences 
IUNA Irish Universities Nutrition Alliance 
IUPAC International Union of Pure and Applied Chemistry 
MCC β-methylcrotonyl-CoA carboxylase 
mRNA messenger ribonucleic acid 
NNR Nordic Nutrition Recommendations 
PC pyruvate carboxylase 
PCC propionyl-CoA carboxylase 
SCF Scientific Committee for Food 
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SD standard deviation 
UL Tolerable Upper Intake Level 
UNU United Nations University 
WHO World Health Organization 
 
